People diagnosed with certain Metastatic Cancers are invited to participate in a paid online survey of treatment and management of these cancers.
People diagnosed with certain Metastatic Cancers are invited to participate in a paid online survey of treatment and management of these cancers.
Northwest Biotherapeutics has applied for approval to market DCVax®, a personalized immune therapy, for the treatment of Glioblastoma.
People diagnosed with certain Metastatic Cancers are invited to participate in a paid online survey of treatment and management of these cancers.
We are looking for Glioblastoma (GBM) patients and their caregivers to participate in an important study on recurrent GBM.
PROSPECT is an open-label, Phase II study evaluating the efficacy, safety, and pharmacokinetics of an oral medicine called Tirabrutinib.
People living with glioblastoma multiforme (GBM) are invited to participate in this online survey about their experience.
The End Brain Cancer Initiative team is proud to be attending the 2023 SNO/ASCO CNS Cancer Conference.
People living with glioblastoma multiforme (GBM) are invited to participate in a paid online survey about their experience.
EBCI is seeking a clinical research nurse to join us in our mission to ensure the best treatment for brain cancer patients.
We are looking for Glioblastoma (GBM) patients and their caregivers to participate in an important study on recurrent GBM.
We are looking to interview patients, and their caregivers, who are living with recurrent glioblastoma (GBM).
National Cancer Institute (NCI) researchers are conducting a study of patients with IDH-mutated gliomas.
